August 28, 2016 3:53 PM ET

Life Sciences Tools and Services

Company Overview of MolecularMD Corp.

Company Overview

MolecularMD Corp. develops and commercializes specialty molecular diagnostics for oncology applications. The company provides molecular diagnostics products and services to pharmaceutical and biotech drug developers. Its products and services are used to select, monitor, and manage response for patients treated with molecularly-targeted cancer therapies in alignment with clinical development and regulatory approval strategies. The company also offers clinical testing services, such as assay development, customized reporting, trial site support, investigator education, laboratory certification, test capacity, data management, and clinical trial IUO kits. In addition, it creates oncology molec...

1341 SW Custer Drive

Portland, OR 97219

United States

Founded in 2005





Key Executives for MolecularMD Corp.

Chief Executive Officer, President and Director
Scientific Co-Founder and Scientific Advisor
Chief Medical Officer, Executive Vice President, Laboratory Director and Director
Scientific Co-Founder
Chief Technology Officer and Executive Vice President
Compensation as of Fiscal Year 2016.

MolecularMD Corp. Key Developments

Illumina Enters into Agreement with MolecularMD for Development of Companion Diagnostics

Illumina has entered into an agreement with Molecular MD that establishes a framework for potential collaborations with respect to the development and commercialization of sequencing-based companion diagnostics. This agreement is designed to deliver the combined power of Illumina's NGS technologies with MolecularMD's ability to tailor a complete clinical development solution including regulatory planning, IDE validations and centralized testing and data management for global patient enrollment and disease monitoring.

Molecularmd Enters into Collaboration Agreement with Illumina for Drug-Diagnostic Co-Development with Biopharma Drug Programs

MolecularMD Corporation announced that it has entered into an agreement with Illumina Inc. that establishes a framework for potential collaborations with respect to the development and commercialization of sequencing-based companion diagnostics in support of biopharma drug development program(s). The agreement dovetails MolecularMD's companion diagnostic development and FDA submission experience with Illumina's NGS technology.

Similar Private Companies By Industry

Company Name Region
10X Genomics, Inc. United States
4G Clinical, Inc. United States
AAPharmaSyn LLC United States
Abiant, Inc. United States
aBioBot, Inc. United States

Recent Private Companies Transactions

Private Placement
July 5, 2016

The information and data displayed in this profile are created and managed by Capital IQ, a Standard & Poor's company. does not create or control the content. For inquiries, please contact Capital IQ directly by clicking here.

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

Most Searched Private Companies

Company Name Geographic Region
Lawyers Committee for Civil Rights Under Law United States
NYC2012, Inc. United States
Bertelsmann AG Europe
Rush University United States
Bloomberg L.P. United States

Sponsored Financial Commentaries

Sponsored Links

Request Profile Update

Only a company representative may request an update for the company profile. Documentation will be required.

To contact MolecularMD Corp., please visit Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at